PFO
AMGN icon

Pathstone Family Office’s Amgen AMGN Stock Holding History

Pathstone Family Office’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$13.8M Buy
49,135
+35,717
+266% +$8.91M 0.11% 130
2023
Q2 		$3.25M Buy
13,418
+1,910
+17% +$443K 0.05% 231
2023
Q1 		$3.32M Sell
11,508
-34,502
-75% -$8.47M 0.05% 202
2022
Q4 		$10.8M Buy
46,010
+13,638
+42% +$3.66M 0.09% 163
2022
Q3 		$8.37M Buy
32,372
+27,445
+557% +$6.65M 0.08% 155
2022
Q2 		$1.2M Buy
4,927
+3,279
+199% +$804K 0.03% 307
2022
Q1 		$980K Sell
1,648
-228
-12% -$52.4K 0.02% 329
2021
Q4 		$425K Sell
1,876
-642
-25% -$135K 0.01% 605
2021
Q3 		$536K Sell
2,518
-1,777
-41% -$409K 0.02% 487
2021
Q2 		$1.05M Buy
4,295
+627
+17% +$154K 0.03% 262
2021
Q1 		$913K Sell
3,668
-1,391
-27% -$332K 0.03% 220
2020
Q4 		$1.16M Buy
5,059
+377
+8% +$86.9K 0.05% 112
2020
Q3 		$1.19M Buy
4,682
+87
+2% +$21.6K 0.13% 75
2020
Q2 		$1.08M Sell
4,595
-937
-17% -$214K 0.13% 76
2020
Q1 		$1.12M Buy
5,532
+871
+19% +$190K 0.16% 75
2019
Q4 		$11.2M Sell
4,661
-18
-0.4% -$3.97K 0.12% 73
2019
Q3 		$906K Sell
4,679
-4,549
-49% -$873K 0.12% 69
2019
Q2 		$1.7M Buy
9,228
+634
+7% +$114K 0.2% 55
2019
Q1 		$1.63M Buy
+8,594
New +$1.64M 0.21% 50
2018
Q2 		– Sell
-138
Closed -$24K – 162
2018
Q1 		$24K Buy
+138
New +$25.3K 0.01% 146
2017
Q3 		– Sell
-1,800
Closed -$310K – 183
2017
Q2 		$310K Sell
1,800
-21
-1% -$3.42K 0.13% 71
2017
Q1 		$298K Sell
1,821
-376
-17% -$62.5K 0.16% 70
2016
Q4 		$321K Buy
+2,197
New +$331K 0.2% 61
2014
Q4 		– Sell
-317
Closed -$45K – 120
2014
Q3 		$45K Buy
+317
New +$41.4K 0.14% 57

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pathstone Family Office's AMGN Position: Q3 2023 in Review

Pathstone Family Office increased its Amgen (AMGN) stake by 266% in Q3 2023, buying an estimated $8.91M and bringing the position to 49,135 shares worth $13.8M. The position accounts for 0.11% of the portfolio, ranked #130.

Pathstone Family Office first reported a position in AMGN in Q3 2014 and has held it in 24 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Pathstone Family Office held 49,135 shares of Amgen worth $13.8M as of Q3 2023.
  • Pathstone Family Office bought 35,717 Amgen shares in Q3 2023, an estimated $8.91M.
  • Amgen made up 0.11% of Pathstone Family Office's portfolio in Q3 2023, its #130 holding.
  • Pathstone Family Office first reported a position in Amgen in Q3 2014 and has held it in 24 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.